Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara M Misof

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Calcified Tissue International|April 26, 2015
Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosisChristian Muschitz, Roland Kocijan, Dieter Pahr, et al.
Bone|October 9, 2022
Accelerated mineralization kinetics in children with osteogenesis imperfecta type 1Barbara M Misof, Paul Roschger, Matthias Mähr, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 10, 2012
Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohortBarbara M Misof, Paul Roschger, Daniela Gabriel, et al.
Bone Reports|March 28, 2020
No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patientsBarbara M Misof, Paul Roschger, Hua Zhou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2017
Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in MineralizationNadja Fratzl-Zelman, Helena Valta, Renata C Pereira, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 30, 2013
Increased heterogeneity of bone matrix mineralization in pediatric patients prone to fractures: a biopsy studyInari S Tamminen, Barbara M Misof, Paul Roschger, et al.
Calcified Tissue International|February 15, 2011
Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnoverNadja Fratzl-Zelman, Paul Roschger, Barbara M Misof, et al.
International Journal of Molecular Sciences|April 30, 2021
Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type IMatthias Mähr, Stéphane Blouin, Martina Behanova, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 9, 2013
Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy studyBarbara M Misof, Janina M Patsch, Paul Roschger, et al.
Endocrinology|October 4, 2017
Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous HyperthyroidismElena Tsourdi, Franziska Lademann, Michael S Ominsky, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Calcified Tissue International|April 26, 2015
Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosisChristian Muschitz, Roland Kocijan, Dieter Pahr, et al.
Bone|October 9, 2022
Accelerated mineralization kinetics in children with osteogenesis imperfecta type 1Barbara M Misof, Paul Roschger, Matthias Mähr, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 10, 2012
Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohortBarbara M Misof, Paul Roschger, Daniela Gabriel, et al.
Bone Reports|March 28, 2020
No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patientsBarbara M Misof, Paul Roschger, Hua Zhou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2017
Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in MineralizationNadja Fratzl-Zelman, Helena Valta, Renata C Pereira, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 30, 2013
Increased heterogeneity of bone matrix mineralization in pediatric patients prone to fractures: a biopsy studyInari S Tamminen, Barbara M Misof, Paul Roschger, et al.
Calcified Tissue International|February 15, 2011
Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnoverNadja Fratzl-Zelman, Paul Roschger, Barbara M Misof, et al.
International Journal of Molecular Sciences|April 30, 2021
Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type IMatthias Mähr, Stéphane Blouin, Martina Behanova, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 9, 2013
Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy studyBarbara M Misof, Janina M Patsch, Paul Roschger, et al.
Endocrinology|October 4, 2017
Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous HyperthyroidismElena Tsourdi, Franziska Lademann, Michael S Ominsky, et al.
Pageof 5